The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: A novel 'Alarmin'?

PLoS ONE

Volumn 3, Issue 10, 2008, Pages

  Moussion, Christine ^a,b   Ortega, Nathalie ^a,b   Girard, Jean Philippe ^a,b  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 33; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG; 4',6 DIAMIDINO 2 PHENYLINDOLE; ACTIN; AUTACOID; DESMIN; FLUORESCENT DYE; IL33 PROTEIN, HUMAN; INDOLE DERIVATIVE; INTERLEUKIN 1; INTERLEUKIN DERIVATIVE;

ARTICLE; BREAST ADENOCARCINOMA; CELL DAMAGE; CELL NUCLEUS; COLON ADENOCARCINOMA; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; IN VIVO STUDY; KERATINOCYTE; KIDNEY CARCINOMA; LIVER CARCINOMA; LUNG ADENOCARCINOMA; PANCREAS ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; SALIVARY GLAND; STOMACH ADENOCARCINOMA; STOMACH EPITHELIUM; TISSUE MICROARRAY; TONSIL CELL; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM;

ACTINS; CELL NUCLEUS; CYTOKINES; DESMIN; ENDOTHELIAL CELLS; EPITHELIAL CELLS; FLUORESCENT DYES; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLES; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKINS;

EID: 53749093767     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003331     Document Type: Article

References (42)

1. Baekkevold ES, Roussigne M, Yamanaka T, Johansen FE, Jahnsen FL, et al. (2003) Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. American Journal of Pathology 163: 69-79.
2. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, et al. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490.
3. Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, et al. (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A 104: 282-287.
4. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, et al. (2007) IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 117: 1538-1549.
5. Allakhverdi Z, Smith DE, Comeau MR, Delespesse G (2007) Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 179: 2051-2054.
6. Iikura M, Suto H, Kajiwara N, Oboki K, Ohno T, et al. (2007) IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest 87: 971-978.
7. Ali S, Huber M, Kollewe C, Bischoff SC, Falk W, et al. (2007) IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci U S A 104: 18660-18665.
8. Hayakawa H, Hayakawa M, Kume A, Tominaga S (2007) Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation. J Biol Chem 282: 26369-26380.
9. Ho LH, Ohno T, Oboki K, Kajiwara N, Suto H, et al. (2007) IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals. J Leukoc Biol 82: 1481-1490.
10. Moulin D, Donze O, Talabot-Ayer D, Mezin F, Palmer G, et al. (2007) Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 40: 216-225.
11. Komai-Koma M, Xu D, Li Y, McKenzie AN, McInnes IB, et al. (2007) IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 37: 2779-2786.
12. Miller AM, Xu D, Asquith DL, Denby L, Li Y, et al. (2008) IL-33 reduces the development of atherosclerosis. J Exp Med 205: 339-346.
13. Chackerian AA, Oldham ER, Murphy EE, Schmitz J, Pflanz S, et al. (2007) IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex. J Immunol 179: 2551-2555.
14. Roussel L, Erard M, Cayrol C, Girard JP (2008) Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Rep.
15. Gadina M, Jefferies CA (2007) IL-33: a sheep in wolf's clothing? Sci STKE 2007: pe31.
16. Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147.
17. Werman A, Werman-Venkert R, White R, Lee JK, Werman B, et al. (2004) The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc Natl Acad Sci U S A 101: 2434-2439.
18. Agresti A, Bianchi ME (2003) HMGB proteins and gene expression. Curr Opin Genet Dev 13: 170-178.
19. Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195.
20. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248-251.
21. Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5: 331-342.
22. Bonaldi T, Talamo F, Scaffidi P, Ferrera D, Porto A, et al. (2003) Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. Embo J 22: 5551-5560.
23. Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81: 1-5.
24. Toccanier-Pelte MF, Skalli O, Kapanci Y, Gabbiani G (1987) Characterization of stromal cells with myoid features in lymph nodes and spleen in normal and pathologic conditions. Am J Pathol 129: 109-118.
25. Bajenoff M, Egen JG, Koo LY, Laugier JP, Brau F, et al. (2006) Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 25: 989-1001.
26. Hauser C, Saurat JH, Schmitt A, Jaunin F, Dayer JM (1986) Interleukin 1 is present in normal human epidermis. J Immunol 136: 3317-3323.
27. Mizutani H, Black R, Kupper TS (1991) Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes. J Clin Invest 87: 1066-1071.
28. Galli SJ, Nakae S, Tsai M (2005) Mast cells in the development of adaptive immune responses. Nat Immunol 6: 135-142.
29. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, et al. (2002) Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3: 673-680.
30. Allakhverdi Z, Comeau MR, Jessup HK, Yoon BR, Brewer A, et al. (2007) Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 204: 253-258.
31. Brunner M, Krenn C, Roth G, Moser B, Dworschak M, et al. (2004) Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma. Intensive Care Med 30: 1468-1473.
32. Shimpo M, Morrow DA, Weinberg EO, Sabatine MS, Murphy SA, et al. (2004) Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 109: 2186-2190.
33. Weinberg EO, Shimpo M, Hurwitz S, Tominaga S, Rouleau JL, et al. (2003) Identification of serum soluble ST2 receptor as a novel heart failure biomarker. Circulation 107: 721-726.
34. Tajima S, Oshikawa K, Tominaga S, Sugiyama Y (2003) The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis. Chest 124: 1206-1214.
35. Oshikawa K, Kuroiwa K, Tago K, Iwahana H, Yanagisawa K, et al. (2001) Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 164: 277-281.
36. Kuroiwa K, Arai T, Okazaki H, Minota S, Tominaga S (2001) Identification of human ST2 protein in the sera of patients with autoimmune diseases. Biochem Biophys Res Commun 284: 1104-1108.
37. Link A, Vogt TK, Favre S, Britschgi MR, Acha-Orbea H, et al. (2007) Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol 8: 1255-1265.
38. Luther SA, Tang HL, Hyman PL, Farr AG, Cyster JG (2000) Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci U S A 97: 12694-12699.
39. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA (2002) Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3: 349-363.
40. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, et al. (2007) The myofibroblast: one function, multiple origins. Am J Pathol 170: 1807-1816.
41. Onda H, Kasuya H, Takakura K, Hori T, Imaizumi T, et al. (1999) Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J Cereb Blood Flow Metab 19: 1279-1288.
42. Weinberg EO, Shimpo M, De Keulenaer GW, MacGillivray C, Tominaga S, et al. (2002) Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 106: 2961-2966.